Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2858-2865

  Kanse, Sandip M ^a,b   Gallenmueller, Andrea ^c   Zeerleder, Sacha ^d,e   Stephan, Femke ^d   Rannou, Olivier ^a   Denk, Stephanie ^c   Etscheid, Michael ^f   Lochnit, Guenter ^a   Krueger, Marcus ^g   Huber Lang, Markus ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d SANQUIN RESEARCH   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f PAUL EHRLICH INSTITUT   (Germany)

^g MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7 ACTIVATING PROTEASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VIVO STUDY; MASS SPECTROMETRY; MULTIPLE TRAUMA; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BLOTTING, WESTERN; COMPLEMENT C5A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE TRAUMA; SERINE ENDOPEPTIDASES; YOUNG ADULT;

EID: 84857843035     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103029     Document Type: Article

References (32)

1. Brohi, K. 2009. Trauma induced coagulopathy. J. R. Army Med. Corps 155: 320-322.
2. Pötzsch, B., and V. Ivaskevicius. 2011. Haemostasis management of massive bleeding. Hamostaseologie 31: 15-20.
3. Keel, M., and O. Trentz. 2005. Pathophysiology of polytrauma. Injury 36: 691-709. (Pubitemid 40732303)
4. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8: 279-289. (Pubitemid 351432799)
5. Xu, J., X. Zhang, R. Pelayo, M. Monestier, C. T. Ammollo, F. Semeraro, F. B. Taylor, N. L. Esmon, F. Lupu, and C. T. Esmon. 2009. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15: 1318-1321.
6. Markiewski, M. M., B. Nilsson, K. N. Ekdahl, T. E. Mollnes, and J. D. Lambris. 2007. Complement and coagulation: strangers or partners in crime? Trends Immunol. 28: 184-192. (Pubitemid 46476881)
7. Conway, E. M. 2012. Thrombomodulin and its role in inflammation. Sem. Immunopathol. 34: 107-125.
8. Römisch, J. 2002. Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol. Chem. 383: 1119-1124. (Pubitemid 35215057)
9. Sedding, D., J. M. Daniel, L. Muhl, K. Hersemeyer, H. Brunsch, B. Kemkes-Matthes, R. C. Braun-Dullaeus, H. Tillmanns, T. Weimer, K. T. Preissner, and S. M. Kanse. 2006. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J. Exp. Med. 203: 2801-2807. (Pubitemid 46026158)
10. Willeit, J., S. Kiechl, T. Weimer, A. Mair, P. Santer, C. J. Wiedermann, and J. Roemisch. 2003. Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis. Circulation 107: 667-670. (Pubitemid 36222589)
11. Ireland, H., G. J. Miller, K. E. Webb, J. A. Cooper, and S. E. Humphries. 2004. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thromb. Haemost. 92: 986-992. (Pubitemid 39545520)
12. Trompet, S., D. Pons, S. M. Kanse, A. J. M. de Craen, M. A. Ikram, J. J. W. Verschuren, A. H. Zwinderman, P. A. F. M. Doevendans, R. A. Tio, R. J. de Winter, et al. 2011. Factor VII activating protease polymorphism (G534E) is associated with increased risk for stroke and mortality. 2011. Stroke Res. Treat. DOI: 10.4061/2011/424759.
13. Gardener, H., A. Beecham, D. Cabral, D. Yanuck, S. Slifer, L. Wang, S. H. Blanton, R. L. Sacco, S. H. Juo, and T. Rundek. 2011. Carotid plaque and candidate genes related to inflammation and endothelial function in Hispanics from northern Manhattan. Stroke 42: 889-896.
14. Zakai, N. A., L. Lange, W. T. Longstreth, Jr., E. S. O'Meara, J. L. Kelley, M. Fornage, D. Nikerson, M. Cushman, and A. P. Reiner. 2011. Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study. J. Thromb. Haemost. 9: 267-274.
15. Yamamichi, S., Y. Fujiwara, T. Kikuchi, M. Nishitani, Y. Matsushita, and K. Hasumi. 2011. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem. Biophys. Res. Com. 409: 483-488.
16. Stephan, F., J. A. Hazelzet, I. Bulder, M. A. Boermeester, J. O. van Till, T. van der Poll, W. A. Wuillemin, L. A. Aarden, and S. Zeerleder. 2011. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit. Care 15: R110.
17. Luber, C. A., J. Cox, H. Lauterbach, B. Fancke, M. Selbach, J. Tschopp, S. Akira, M. Wiegand, H. Hochrein, M. O'Keeffe, and M. Mann. 2010. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32: 279-289.
18. Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21: 3820-3829. (Pubitemid 32466993)
19. Römisch, J., A. Feussner, and H. A. Stöhr. 2001. Quantitation of the factor VII-and single-chain plasminogen activator-activating protease in plasmas of healthy subjects. Blood Coagul. Fibrinolysis 12: 375-383. (Pubitemid 32730497)
20. Seelen, M. A., A. Roos, J. Wieslander, T. E. Mollnes, A. G. Sjöholm, R. Wurzner, M. Loos, F. Tedesco, R. B. Sim, P. Garred, et al. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296: 187-198. (Pubitemid 40174752)
21. Amara, U., M. A. Flierl, D. Rittirsch, A. Klos, H. Chen, B. Acker, U. B. Brückner, B. Nilsson, F. Gebhard, J. D. Lambris, and M. Huber-Lang. 2010. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185: 5628-5636.
22. Holdenrieder, S., and P. Stieber. 2009. Clinical use of circulating nucleosomes. Crit. Rev. Clin. Lab. Sci. 46: 1-24.
23. Butt, A. N., and R. Swaminathan. 2008. Overview of circulating nucleic acids in plasma/serum. Ann. N. Y. Acad. Sci. 1137: 236-242.
24. Schmaier, A. H. 2008. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int. Immunopharmacol. 8: 161-165.
25. Huber-Lang, M., J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff, S. R. McGuire, J. D. Lambris, R. L. Warner, M. A. Flierl, L. M. Hoesel, et al. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12: 682-687. (Pubitemid 43865238)
26. Weisel, J. W. 2005. Fibrinogen and fibrin. Adv. Protein Chem. 70: 247-299. (Pubitemid 40544785)
27. Siciliano, S. J., T. E. Rollins, J. DeMartino, Z. Konteatis, L. Malkowitz, G. Van Riper, S. Bondy, H. Rosen, and M. S. Springer. 1994. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 91: 1214-1218. (Pubitemid 24058980)
28. Bolliger, D., K. Görlinger, and K. A. Tanaka. 2010. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 113: 1205-1219.
29. Brummel-Ziedins, K., M. F. Whelihan, E. G. Ziedins, and K. G. Mann. 2006. The resuscitative fluid you choose may potentiate bleeding. J. Trauma 61: 1350-1358.
30. Hecke, F., U. Schmidt, A. Kola, W. Bautsch, A. Klos, and J. Köhl. 1997. Circulating complement proteins in multiple trauma patients: correlation with injury severity, development of sepsis, and outcome. Crit. Care Med. 25: 2015-2024. (Pubitemid 28007240)
31. Woodruff, T. M., K. S. Nandakumar, and F. Tedesco. 2011. Inhibiting the C5-C5a receptor axis. Mol. Immunol. 48: 1631-1642.
32. Woehrl, B., M. C. Brouwer, C. Murr, S. G. Heckenberg, F. Baas, H. W. Pfister, A. H. Zwinderman, B. P. Morgan, S. R. Barnum, A. van der Ende, et al. 2011. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J. Clin. Invest. 121: 3943-3953.